ArticleJournal of clinical medicine2019

KIFC1 Inhibitor CW069 Induces Apoptosis and Reverses Resistance to Docetaxel in Prostate Cancer.

Yohei Sekino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.